Anavex Life Sciences
AVXL
#7559
Rank
S$0.51 B
Marketcap
S$5.72
Share price
1.61%
Change (1 day)
-48.60%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -S$68.42 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$66.85 Million a decrease over its 2023 earnings that were of -S$58.25 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$68.42 Million2.34%
2024 -S$66.85 Million14.77%
2023 -S$58.25 Million-17.49%
2022 -S$70.6 Million22.96%
2021 -S$57.41 Million35.36%
2020 -S$42.42 Million12.65%
2019 -S$37.65 Million29.09%
2018 -S$29.17 Million36.33%
2017 -S$21.4 Million17.11%
2016 -S$18.27 Million20.91%
2015 -S$15.11 Million-6.29%
2014 -S$16.13 Million337.28%
2013 -S$3.69 Million
2008 -S$6.82 Million106.01%
2007 -S$3.31 Million8848.98%
2006 -S$0.04 Million-79.99%
2005 -S$0.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
S$86.6 M-228.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-S$8.58 Million-87.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
S$85.02 M-225.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-S$22.43 Million-66.78%๐Ÿ‡บ๐Ÿ‡ธ USA